Ankit Patel

Surgical Oncology

About Ankit Patel


Roswell Park Comprehensive Cancer Center

  • Fellow
  • Department of Surgical Oncology


Education and Training:

  • 2013 - MD - Robert Wood Johnson Medical School, New Brunswick, NJ
  • 2009 - BS - Rutgers University, New Brunswick, NJ


  • 2013-2020 - General Surgery Residency at the University of Rochester, Rochester, NY


  • 2015-2017 - Research Fellow at the Center of Tumor Immunology, University of Rochester, Rochester, NY

Professional Memberships:

  • American College of Surgeons
  • Society of Surgical Oncology
  • American Association for Cancer Research


Nywening TM, Belt BA, Cullinan DR, Panni RZ, Han BJ, Sanford DE, Jacobs RC, Ye J, Patel A, Gillanders WE and Fields RC. “Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.” Gut, pp.gutjnl (2017). PMID: 29196437

Connolly KA, Belt BA, Figueroa NM, Murthy A, Patel A, Kim M, Lord EM, Linehan DC, and Gerber SA. "Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes." Oncotarget, Vol 7, no. 52 (2016): 86522. PMID: 27852031

Mills BN, Connolly KA, Ye J, Murphy JD, Uccello TP, Han BJ, Zhao T, Drage MG, Murthy A, Qiu H, Patel A, Figueroa NM, Johnston CJ, Prieto PA, Egilmez NK, Belt BA, Lord EM, Linehan DC, Gerber SA. “Stereotactic body radiation and Interleukin-12 combination therapy eradicates pancreatic tumors by repolarizing the immune environment.” Cell Reports, No 29, pg 406-421 (2018). PMID: 31597100